Abstract
Increased plasma homocysteine concentrations are associated with increased risks of myocardial infarction, stroke, and venous thrombosis. Potential benefits of homocysteine-lowering therapy are stimulating clinical interest in measuring homocysteine. Many methods are now available including some new options. However, homocysteine testing and interpretation present challenges to clinical laboratories. Future demand for homocysteine testing likely will depend on the outcome of ongoing trials of homocysteine-lowering therapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
